REVIVE AT CYCLE MEETING

REVIVE AT CYCLE MEETING

1st Grade

10 Qs

quiz-placeholder

Similar activities

Review Keperawatan Anak 1

Review Keperawatan Anak 1

1st - 3rd Grade

10 Qs

Posyandu Lansia

Posyandu Lansia

1st - 3rd Grade

5 Qs

Crash Course , CCD

Crash Course , CCD

1st - 3rd Grade

9 Qs

Keyboard Shortcut (1)

Keyboard Shortcut (1)

1st Grade

15 Qs

Uji Pemahaman Prolanis

Uji Pemahaman Prolanis

1st - 5th Grade

10 Qs

Hypo Hyper

Hypo Hyper

1st - 3rd Grade

10 Qs

FMA SUAP 2019

FMA SUAP 2019

1st Grade

10 Qs

PRE TEST - UJI PEMAHAMAN PIC PROLANIS

PRE TEST - UJI PEMAHAMAN PIC PROLANIS

KG - Professional Development

15 Qs

REVIVE AT CYCLE MEETING

REVIVE AT CYCLE MEETING

Assessment

Quiz

Professional Development

1st Grade

Medium

Created by

Sayalee Kesarkar

Used 2+ times

FREE Resource

10 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

With me 2 weeks of treatment can give the patients 10 weeks of relief from abdominal pain and diarrhoea. Who am I?

Acogut

Rcifax

Cizaspa SR

Pegalup

2.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

Acogut 300 ER "increases accomodation and improves _________".

Dyspepsia

Hyperacidity

Gut motiliy

Quality of life

3.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

Hyperuricemia leads to painful gout arthritis. So, aim is to reduce sUA levels to __

< 10 mg/dl

> 8mg/dl

< 6 mg/dl

< 8-9 mg/dl

4.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

The recommended dosage of UDCA in Cholestatic Liver disease is _____

13-15 mg/kg body weight

10-12 mg/kg body weight

6-10 mg/kg body weight

4-5 mg/kg body weight

5.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

Acogut gives signifcant to complete relief from meal related _____ symptoms.

Epigastric pain syndrome

Dyspepsia

Irritable bowel syndrome

Post prandial distress syndrome

6.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

Dr Ghosh shared that his patient is suffering from Cholelithiasis and is obese weighing around 105 kgs. Which of the following would be the right prescription for his patient?

Ulyses 300 BID

Acogut 300 OD

Rcifax 400 TID

Ulyses 450 SR TID

7.

MULTIPLE CHOICE QUESTION

45 sec • 1 pt

"The percentage of patients requiring treatment for gout flares declined to zero after 5 years of treatment with Febuxostat".

This concluding statement has been taken from which trial?

Confirm Trial

Focus Trial

Freed Trial

Journal of Clinical Rheumtology

Create a free account and access millions of resources

Create resources
Host any resource
Get auto-graded reports
or continue with
Microsoft
Apple
Others
By signing up, you agree to our Terms of Service & Privacy Policy
Already have an account?